Afya Limited (AFYA) short interest & options flow
NASDAQTwo analysts moved on AFYA on Monday. The signals point in opposite directions, and that tension is the story heading into a November 12 earnings print. Citigroup's Leandro Bastos upgraded Afya to Buy from Neutral. The target fell to $12 from $16. With the stock at $10.64, that implies around 13% upside, but the slashed target acknowledges that the selloff which has taken Afya down…
AFYA upgraded to Buy by Citigroup, though target slashed to $12 from $16; stock at $10.64, down 13% month-to-date as short interest collapses.
Short interest % of float, cost to borrow, utilization, and put/call ratio for AFYA are part of the ORTEX premium tier. Sign up to read the live numbers alongside the analysis.
- Market cap
- $925M
- Next earnings
- 12 Nov 2026
Key data as of 3 Nov 2026
Latest signals on AFYA
- Analyst
AFYA upgraded to Buy by Citigroup, though target slashed to $12 from $16; stock at $10.64, down 13% month-to-date as short interest collapses.
2 Analyst updates in 30 days
- Cost to Borrow
AFYA cost to borrow surges to 6.98%, up 185% over the past week, as shares available to short fall sharply.
3 Cost to Borrow updates in 30 days
- Short Interest
AFYA short interest
3 Short Interest updates in 30 days
- Utilization
AFYA short squeeze potential surges: utilization hits 52-week high of 93.82%, availability plummets to 19.94%, lowest in a year.
AFYA news and analysis
RSSNo long-form analysis yet for AFYA. Pulse alerts and the live data picture are available on ORTEX.
Open AFYA on ORTEX →Want the live picture for AFYA?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for AFYA — free to start on ORTEX.
Sign up for free →Open AFYA on ORTEX